IP Library Granted Patent US 12667574
Granted Patent B2
US 12667574 · App. 17/965,754 · Granted Jun 30, 2026

Paraxanthine-based bioactive composition and method of use thereof

Inventors: Shawn Wells (Frisco, TX); Ralf Jager (Milwaukee, WI); Kylin Liao (Plano, TX); Martin Purpura (Spring, TX)
Assignee: PX ING, LLC
A61K31/522A23L33/10A61K31/685A61K45/06A61P25/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12667574
App. No.
17/965,754
Granted
Jun 30, 2026
Kind
B2
Abstract

The disclosed compositions and methods relate to compositions for human consumption comprising paraxanthine and a cholinergic agent and/or theanine. The disclosed compositions are useful for promoting cognitive function, energy, athletic performance and providing neuroprotective anti-oxidative effects.

Claims (16)

1 . A method for improving physical performance in a subject, comprising: providing the subject with a composition comprising about 50 mg to about 800 mg of paraxanthine and an effective amount of alpha-GPC (L-alpha glycerylphosphorylcholine).

2 . The method of claim 1 , wherein paraxanthine is present in the composition in an amount from about 50 mg to about 400 mg.

3 . The method of claim 2 , wherein the alpha-GPC is present in the composition in an amount from about 50 mg to about 400 mg.

4 . The method of claim 2 , wherein the composition is substantially free of caffeine.

5 . The method of claim 2 , wherein administration of the composition to a subject produces a synergistic increase in physical performance relative to the administration of a comparable dose of paraxanthine or alpha-GPC.

6 . The method of claim 1 further comprising a paraxanthine congener or paraxanthine analog selected from the group consisting of caffeine, methyl caffeine, theobromine, theophylline, liberine, methylliberine, theacrine and combinations thereof.

7 . The method of claim 6 , wherein the paraxanthine congener or paraxanthine analog is caffeine.

8 . A method of improving cognitive function in a subject comprising administering to the subject a composition comprising about 50 mg to about 800 mg of paraxanthine and an effective amount of alpha-GPC.

9 . The method of claim 8 , wherein administration of the composition increases one or more of attention, information acquisition, information processing, working memory, short-term memory, long-term memory, anterograde memory, retrograde memory, memory retrieval, discrimination learning, decision-making, inhibitory response control, attentional set-shifting, delayed reinforcement learning, reversal learning, the temporal integration of voluntary behavior, speed of processing, reasoning, problem solving and/or social cognition.

10 . The method of claim 9 , wherein administration of the composition enhances dopaminergic tone, cholinergic tone, and/or brain BDNF levels.

11 . The method of claim 8 , wherein administration of the composition is neuroprotective against oxidative stress.

12 . The method of claim 8 further comprising a paraxanthine congener or paraxanthine analog selected from the group consisting of caffeine, methyl caffeine, theobromine, theophylline, liberine, methylliberine, theacrine and combinations thereof.

13 . The method of claim 8 , wherein the alpha-GPC is present in the composition in an amount from about 50 mg to about 400 mg.

14 . The method of claim 8 , wherein the composition is substantially free of caffeine.

15 . The method of claim 8 , wherein administration of the composition to a subject produces a synergistic increase in cognitive function relative to the administration of a comparable dose of paraxanthine or alpha-GPC.

16 . A method for enhancing energy in a subject comprising administering to the subject a composition comprising about 50 mg to about 800 mg of paraxanthine and an effective amount of alpha-GPC.